MBX BIOSCIENCES INC (MBX) Stock Cash Flow
USA - NASDAQ:MBX - US55287L1017 - Common Stock
16.13 USD
+1.35 (+9.13%)
16.01 USD
-0.12 (-0.74%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -77.02M | -61.92M | -32.56M | -26.14M | |||
| Depreciation Amortization | 271.00K | 244.00K | 157.00K | 56.00K | |||
| Change In Working Capital | 3.66M | 4.60M | -735.00K | 1.29M | |||
| Other non cash items | 2.27M | 2.40M | 1.16M | 1.67M | |||
| OPERATING CASH FLOW | -70.81M | -54.68M | -31.98M | -23.12M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -886.00K | -874.00K | -129.00K | -441.00K | |||
| Other Investing Activity | -138.03M | -159.72M | -30.80M | -10.97M | |||
| INVESTING CASH FLOW | -138.92M | -160.59M | -30.93M | -11.41M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 10.00M | |||
| Stock Issued/Repurchased | 239.54M | 238.44M | 69.25M | 36.52M | |||
| Other Financing Activity | -2.52M | -4.34M | -30.00K | -458.00K | |||
| FINANCING CASH FLOW | 237.01M | 234.10M | 69.22M | 46.06M | |||
| CHANGE IN CASH | 27.28M | 18.83M | 6.31M | 11.53M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -70.81M | -54.68M | -31.98M | -23.12M | |||
| Capital Expenditure | -886.00K | -874.00K | -129.00K | -441.00K | |||
| FREE CASH FLOW | -71.70M | -55.55M | -32.11M | -23.56M | |||
All data in USD